This infographic explores how patients and practitioners alike can overcome the challenges of urine collection.
When properly collected, first-void urine, the first 10 mL- 40 mL of urine, can help detect breast, ovarian, and pancreatic cancer and screen for sexually transmitted infections such as human papillomavirus and chlamydia. But this low-cost, non-invasive procedure presents challenges that can impact patient experience, accuracy of results, and research. Now there is a novel first-void urine collection device that is producing better outcomes, and that 97% of users would use again.
Get the infographic that explores why sample collection is so challenging and the novel device that is a reliable solution. You’ll learn:
- Which top challenges this device can overcome.
- Step-by-step instructions on how this device works.
- Statistics on sample accuracy.
- How patients are embracing this solution.
Offered Free by: BioPharma Dive’s studioID and DNA Genotek
See All Resources from: BioPharma Dive’s studioID and DNA Genotek
